日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Assessment of targets of antibody drug conjugates in SCLC

小细胞肺癌中抗体药物偶联物靶点的评估

Ajay, Abhishek; Wang, Han; Rezvani, Ali; Savari, Omid; Grubb, Brandon J; McColl, Karen S; Yoon, Suzy; Joseph, Peronne L; Kopp, Shelby R; Kresak, Adam M; Peacock, Craig D; Wildey, Gary M; Lam, Minh; Miyagi, Masaru; Kao, Hung-Ying; Dowlati, Afshin

Comprehensive Analysis of the Value of Dynamic Changes in Circulating Tumor DNA in Small Cell Lung Cancer

小细胞肺癌中循环肿瘤DNA动态变化价值的综合分析

Ajay, Abhishek; Ferdousi, Reza; Joseph, Peronne L; Durer, Seren; Rezvani, Ali; Chen, Zhengyi; Wildey, Gary M; Lam, Minh; Fu, Pingfu; Dowlati, Afshin

Identification of HEPACAM2 as a novel and specific marker of small cell carcinoma.

鉴定 HEPACAM2 为小细胞癌的新型特异性标志物

McColl Karen S, Ajay Abhishek, Wang Han, Wildey Gary M, Yoon Suzy, Grubb Brandon, Kopp Shelby R, Joseph Peronne L, Saviana Michela, Romano Giulia, Nana-Sinkam Patrick, Peacock Craig D, Yun Zixi, Mneimneh Wadad, Lam Minh, Miyagi Masaru, Kao Hung-Ying, Dowlati Afshin

Retinoblastoma Expression and Targeting by CDK4/6 Inhibitors in Small Cell Lung Cancer.

视网膜母细胞瘤表达及 CDK4/6 抑制剂在小细胞肺癌中的靶向作用

Wildey Gary, Shay Ashley M, McColl Karen S, Yoon Suzy, Shatat Mohammad A, Perwez Ahmad, Spainhower Kyle B, Kresak Adam M, Lipka MaryBeth, Yang Michael, Behtaj Mohadese, Fu Pingfu, Alahmadi Asrar, Mneimneh Wadad, Abbas Ata, Dowlati Afshin

CBL0137 increases the targeting efficacy of Rovalpituzumab tesirine against tumour-initiating cells in small cell lung cancer

CBL0137 可提高罗伐妥珠单抗对小细胞肺癌肿瘤起始细胞的靶向疗效

Lindner, Daniel J; Wildey, Gary; Parker, Yvonne; Dowlati, Afshin; Stark, George R; De, Sarmishtha

Sars-Cov-2 Spike Protein Induces Cellular Changes in Primitive and Mature Hematopoietic Cells

SARS-CoV-2 刺突蛋白诱导原始和成熟造血细胞发生细胞变化

Jiang, Guoping; Yang, Horng-Ren; Wang, Lianfu; Wildey, Gary M; Fung, John; Qian, Shiguang; Lu, Lina; Ropa, James; Cooper, Scott; Capitano, Maegan L; Broxmeyer, Hal E

Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2: CALGB 151111 (Alliance)

小细胞肺癌表现出组蛋白甲基转移酶 KMT2D/MLL2 的频繁失活突变:CALGB 151111(联盟)

Augert, Arnaud; Zhang, Qing; Bates, Breanna; Cui, Min; Wang, Xiaofei; Wildey, Gary; Dowlati, Afshin; MacPherson, David

Genomic alterations in small cell lung cancer and their clinical relevance

小细胞肺癌的基因组改变及其临床意义

Wildey, Gary; Dowlati, Afshin

CD30 is a potential therapeutic target in malignant mesothelioma.

CD30是恶性间皮瘤的潜在治疗靶点

Dabir Snehal, Kresak Adam, Yang Michael, Fu Pingfu, Wildey Gary, Dowlati Afshin

Runx1 is a co-activator with FOXO3 to mediate transforming growth factor beta (TGFbeta)-induced Bim transcription in hepatic cells

Runx1与FOXO3共同激活,介导转化生长因子β(TGFβ)诱导的肝细胞中Bim转录。

Wildey, Gary M; Howe, Philip H